<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02985008</url>
  </required_header>
  <id_info>
    <org_study_id>2016-03-130</org_study_id>
    <nct_id>NCT02985008</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic Shock</brief_title>
  <acronym>SMART-RESCUE</acronym>
  <official_title>SMart Angioplasty Research Team: A Multi-center, Open, REtrospective and Prospective Observational Study to Investigate Clinical oUtcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic Shock : RESCUE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jeong Hoon Yang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospectively and prospectively enrolled patients with cardiogenic shock in domestic
      manifolds and investigated the current state of treatment and clinical features of
      cardiogenic shock in Koreans and identified the factors that could improve the prognosis and
      the use of IABP and ECMO And to investigate its therapeutic effect.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. The selection / exclusion criteria for persons with cardiogenic shock should be verified
           by medical records from January 1, 2014 before the approval date of each institution's
           clinical trial screening committee.

        2. If a cardiogenic shock to the selection criteria is found in the emergency room, general
           ward, or intensive care unit of the participating institutions, enroll in this study and
           fill in the information according to the e-CRF.

        3. After 1, 6 and 12 months, visit the hospital for examination and procedures. The person
           in charge of the examination or the delegate of the examiner may follow the person by
           telephone or an outpatient visit.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>In hospital death</measure>
    <time_frame>for 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death in 28days</measure>
    <time_frame>28days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death in 1 year</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death, myocardial infarction, stroke, re-admission due to heart failure during follow-up.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days of intensive care unit Number of days of intensive care unit</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospitalization days</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactate 24 hour clearance</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Successful removal of left ventricular assist device (IABP, ECMO)</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Shock, Cardiogenic</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Total: 1,000

          -  Cardiogenic shock group with inserted IABP, ECMO : 400

          -  Cardiogenic shock group without inserted IABP, ECMO : 600
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 19 years old or older

          2. ① Systolic blood pressure is less than 90mmHg for more than 30 minutes despite the
             fluid therapy, or Use of pressure boosting agents is necessary.

             ② Peripheral hypopnea (cold skin, urine less than 30 cc per hour, impaired
             consciousness, lactate ≥2.0 mmol / l) or a person with pulmonary edema.

          3. Causes of cardiogenic shock include acute myocardial infarction (including in coronary
             intervention), cardiomyopathy, myocarditis, pulmonary embolism, refractory ventricular
             tachycardia, shock during coronary intervention.

          4. Those voluntarily consenting to the medical records and the data necessary for the
             study during the entire study period.

        Exclusion Criteria:

          1. Other causes except for cardiogenic shock (low blood pressure, septic, obstructive
             shock)

          2. Shock with cardiac arrest outside the hospital

          3. People with allergic reactions to anticoagulants such as heparin.

          4. Those who refused active treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeong Hoon Yang</last_name>
    <role>Study Chair</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeong Hoon Yang</last_name>
    <phone>+82-10-4872-9433</phone>
    <email>jeonghoon.yang@samsung.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jin Hee Seo</last_name>
    <phone>+82-10-6623-5673</phone>
    <email>rufina.seo@samsung.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul City</city>
        <state>Seoul</state>
        <zip>KS013</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeong Hoon Yang</last_name>
      <email>jeonghoon.yang@samsung.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Thiele H, Allam B, Chatellier G, Schuler G, Lafont A. Shock in acute myocardial infarction: the Cape Horn for trials? Eur Heart J. 2010 Aug;31(15):1828-35. doi: 10.1093/eurheartj/ehq220. Epub 2010 Jul 7. Review.</citation>
    <PMID>20610640</PMID>
  </reference>
  <reference>
    <citation>Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Böhm M, Ebelt H, Schneider S, Werdan K, Schuler G; Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013 Nov 16;382(9905):1638-45. doi: 10.1016/S0140-6736(13)61783-3. Epub 2013 Sep 3.</citation>
    <PMID>24011548</PMID>
  </reference>
  <reference>
    <citation>Rousse N, Juthier F, Pinçon C, Hysi I, Banfi C, Robin E, Fayad G, Jegou B, Prat A, Vincentelli A. ECMO as a bridge to decision: Recovery, VAD, or heart transplantation? Int J Cardiol. 2015;187:620-7. doi: 10.1016/j.ijcard.2015.03.283. Epub 2015 Mar 20.</citation>
    <PMID>25863737</PMID>
  </reference>
  <reference>
    <citation>Napp LC, Brehm M, Kühn C, Schäfer A, Bauersachs J. Heart against veno-arterial ECMO: Competition visualized. Int J Cardiol. 2015;187:164-5. doi: 10.1016/j.ijcard.2015.03.311. Epub 2015 Mar 21.</citation>
    <PMID>25828345</PMID>
  </reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2016</study_first_submitted>
  <study_first_submitted_qc>December 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2016</study_first_posted>
  <last_update_submitted>December 5, 2016</last_update_submitted>
  <last_update_submitted_qc>December 5, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Jeong Hoon Yang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Shock, IVBP, ECMO, In hospital death</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Cardiogenic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

